113 reports of this reaction
1.4% of all POLYVINYL ALCOHOL, POVIDONE reports
#19 most reported adverse reaction
EYE SWELLING is the #19 most commonly reported adverse reaction for POLYVINYL ALCOHOL, POVIDONE, manufactured by Geri-Care Pharmaceuticals, Corp. There are 113 FDA adverse event reports linking POLYVINYL ALCOHOL, POVIDONE to EYE SWELLING. This represents approximately 1.4% of all 8,211 adverse event reports for this drug.
Patients taking POLYVINYL ALCOHOL, POVIDONE who experience eye swelling should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
EYE SWELLING is a less commonly reported adverse event for POLYVINYL ALCOHOL, POVIDONE, but still significant enough to appear in the safety profile.
In addition to eye swelling, the following adverse reactions have been reported for POLYVINYL ALCOHOL, POVIDONE:
The following drugs have also been linked to eye swelling in FDA adverse event reports:
EYE SWELLING has been reported as an adverse event in 113 FDA reports for POLYVINYL ALCOHOL, POVIDONE. This does not prove causation, but indicates an association observed in post-market surveillance data.
EYE SWELLING accounts for approximately 1.4% of all adverse event reports for POLYVINYL ALCOHOL, POVIDONE, making it a notable side effect.
If you experience eye swelling while taking POLYVINYL ALCOHOL, POVIDONE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.